Relmada Therapeutics Insider Trades

RLMD

Track insider trading activity from Relmada Therapeutics executives and directors. See which insiders are buying and selling RLMD stock.

Trades Last 12 Months

RLMD Price

All Insider Trades for Relmada Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Traversa Sergio Chief Executive Officer
Holding Value $8.23M 1,300,000 shares
Last Trade
Dec 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$113k 27,500 shares
$4.12
$6.33
Shenouda Maged Chief Financial Officer
Holding Value $5.06M 800,000 shares
Last Trade
Dec 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.1k 11,665 shares
$4.12
$6.33
Ence Chuck CA And CO
Holding Value $5.24M 828,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 828,000 shares
$4.06
$6.33
Fedeli Fabiana Director
Holding Value $1.04M 164,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 164,000 shares
$4.06
$6.33
Glasspool John Director
Holding Value $1.04M 164,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 164,000 shares
$4.06
$6.33
Holding Value $5.24M 828,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 828,000 shares
$4.06
$6.33
Holding Value $1.04M 164,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$666k 164,000 shares
$4.06
$6.33
Holding Value $950k 150,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 92,958 shares
$2.84
$6.33
O'gorman Cedric Chief Medical Officer
Holding Value $64.1k 10,121 shares
Last Trade
May 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.8k 10,000 shares
$3.18
$6.33
Wessel Thomas Evp, Head Of R&d
Holding Value $0 0 shares
Last Trade
Mar 09, 2020 Sale
$16M 350,000 shares
$45.61
$6.33
Holding Value $665k 105,000 shares
Last Trade
Dec 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.56M 105,000 shares
$43.47
$6.33
Holding Value $36.5k 5,759 shares
Last Trade
Dec 31, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$760 400 shares
$1.90
$6.33
Seth Sandesh Director
Holding Value $749k 118,258 shares
Last Trade
Dec 15, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.8k 2,000 shares
$1.90
$6.33
Salinas Eliseo Oreste President And CSO
Holding Value $1.59M 250,944 shares
Last Trade
Feb 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$428k 225,000 shares
$1.90
$6.33
Beck Douglas Chief Financial Officer
Holding Value $661k 104,437 shares
Last Trade
Feb 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 25,000 shares
$1.90
$6.33
Yazgi Nabil Director
Holding Value $0 0 shares
Last Trade
Jan 06, 2015 Sale
$92.5k 48,662 shares
$1.90
$6.33

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up